Reduced SMN Protein Impairs Maturation of the Neuromuscular Junctions in Mouse Models of Spinal Muscular Atrophy

Overview

Journal Hum Mol Genet

Specialties Genetics
Molecular Biology

Date 2008 May 22

PMID 18492800

Citations 254

Authors

Shingo Kariya

Gyu-Hwan Park

Yuka Maeno-Hikichi

Olga Leykekhman

Cathleen Lutz

Marc S Arkovitz

Lynn T Landmesser

Umrao R Monani

Affiliations

Soon will be listed here.

Abstract

Spinal muscular atrophy (SMA) is a common pediatric neuromuscular disorder caused by insufficient levels of the survival of motor neuron (SMN) protein. Studies involving SMA patients and animal models expressing the human SMN2 gene have yielded relatively little information about the earliest cellular consequences of reduced SMN protein. In this study, we have used severe- and mild-SMN2 expressing mouse models of SMA as well as material from human patients to understand the initial stages of neurodegeneration in the human disease. We show that the earliest structural defects appear distally and involve the neuromuscular synapse. Insufficient SMN protein arrests the post-natal development of the neuromuscular junction (NMJ), impairing the maturation of acetylcholine receptor (AChR) clusters into 'pretzels'. Pre-synaptic defects include poor terminal arborization and intermediate filament aggregates which may serve as a useful biomarker of the disease. These defects are reflected in functional deficits at the NMJ characterized by intermittent neurotransmission failures. We suggest that SMA might best be described as a NMJ synaptopathy and that one promising means of treating it could involve maintaining function at the NMJ.

Citing Articles

Identifying novel response markers for spinal muscular atrophy revealed by targeted proteomics following gene therapy.

Pant D, Verma S Gene Ther. 2025; .

PMID: 39794476 DOI: 10.1038/s41434-025-00513-0.

Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models.

Pagliari E, Taiana M, Manzini P, Sali L, Quetti L, Bertolasi L Cell Mol Life Sci. 2024; 82(1):29.

PMID: 39725771 PMC: 11671459. DOI: 10.1007/s00018-024-05550-3.

Motor pool selectivity of neuromuscular degeneration in type I spinal muscular atrophy is conserved between human and mouse.

Lee J, Chung W, Pisapia D, Henderson C Hum Mol Genet. 2024; 34(4):347-367.

PMID: 39690843 PMC: 11811418. DOI: 10.1093/hmg/ddae190.

Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes.

Brambilla L, Valori C, Guidotti G, Martorana F, Sulmona C, De Martini L Transl Neurodegener. 2024; 13(1):63.

PMID: 39681882 PMC: 11650830. DOI: 10.1186/s40035-024-00455-4.

A variant of the Hspa8 synaptic chaperone modifies disease in a SOD1 mouse model of amyotrophic lateral sclerosis.

Takeda T, Her Y, Kim J, Jha N, Monani U Exp Neurol. 2024; 383:115024.

PMID: 39454934 PMC: 11611598. DOI: 10.1016/j.expneurol.2024.115024.

References

VITALI T, Sossi V, Tiziano F, Zappata S, Giuli A, Neri G . Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role for SMN2 in the modulation of disease severity in SMA patients. Hum Mol Genet. 1999; 8(13):2525-32. DOI: 10.1093/hmg/8.13.2525. View

Missias A, Chu G, Klocke B, Sanes J, Merlie J . Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch. Dev Biol. 1996; 179(1):223-38. DOI: 10.1006/dbio.1996.0253. View

Trachtenberg J, Thompson W . Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature. 1996; 379(6561):174-7. DOI: 10.1038/379174a0. View

McWhorter M, Monani U, Burghes A, Beattie C . Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol. 2003; 162(5):919-31. PMC: 1761110. DOI: 10.1083/jcb.200303168. View

Crawford T, Pardo C . The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996; 3(2):97-110. DOI: 10.1006/nbdi.1996.0010. View

Swoboda K, Prior T, Scott C, McNaught T, Wride M, Reyna S . Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol. 2005; 57(5):704-12. PMC: 4334582. DOI: 10.1002/ana.20473. View

Le T, Pham L, Butchbach M, Zhang H, Monani U, Coovert D . SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005; 14(6):845-57. DOI: 10.1093/hmg/ddi078. View

Sharma A, Lambrechts A, Hao L, Le T, Sewry C, Ampe C . A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells. Exp Cell Res. 2005; 309(1):185-97. DOI: 10.1016/j.yexcr.2005.05.014. View

Murray L, Comley L, Thomson D, Parkinson N, Talbot K, Gillingwater T . Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet. 2007; 17(7):949-62. DOI: 10.1093/hmg/ddm367. View

10.

Tu P, Gurney M, Julien J, Lee V, Trojanowski J . Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Invest. 1997; 76(4):441-56. View

11.

Sanes J, Lichtman J . Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci. 2001; 2(11):791-805. DOI: 10.1038/35097557. View

12.

Pagliardini S, Giavazzi A, Setola V, Lizier C, Di Luca M, Debiasi S . Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum Mol Genet. 1999; 9(1):47-56. DOI: 10.1093/hmg/9.1.47. View

13.

Munsat T, Davies K . International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992; 2(5-6):423-8. DOI: 10.1016/s0960-8966(06)80015-5. View

14.

Shafey D, Cote P, Kothary R . Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Exp Cell Res. 2005; 311(1):49-61. DOI: 10.1016/j.yexcr.2005.08.019. View

15.

Jevsek M, Jaworski A, Polo-Parada L, Kim N, Fan J, Landmesser L . CD24 is expressed by myofiber synaptic nuclei and regulates synaptic transmission. Proc Natl Acad Sci U S A. 2006; 103(16):6374-9. PMC: 1435367. DOI: 10.1073/pnas.0601468103. View

16.

Broccolini A, Engel W, Askanas V . Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibers, and neuromuscular junctions. Neuroreport. 1999; 10(8):1637-41. DOI: 10.1097/00001756-199906030-00003. View

17.

Zhang H, Pan F, Hong D, Shenoy S, Singer R, Bassell G . Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci. 2003; 23(16):6627-37. PMC: 6740639. View

18.

McAndrew P, Parsons D, Simard L, Rochette C, Ray P, Mendell J . Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet. 1997; 60(6):1411-22. PMC: 1716150. DOI: 10.1086/515465. View

19.

Braun S, Croizat B, Lagrange M, Warter J, Poindron P . Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet. 1995; 345(8951):694-5. DOI: 10.1016/s0140-6736(95)90869-2. View

20.

Polo-Parada L, Bose C, Landmesser L . Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions. Neuron. 2001; 32(5):815-28. DOI: 10.1016/s0896-6273(01)00521-9. View